New Risk • Jun 11
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 54% per year over the past 5 years. Shareholders have been substantially diluted in the past year (175% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩60.7b market cap, or US$39.7m). New Risk • Jun 01
New major risk - Revenue and earnings growth Earnings have declined by 54% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 54% per year over the past 5 years. Shareholders have been substantially diluted in the past year (81% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (₩38.5b market cap, or US$25.5m). New Risk • Apr 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (81% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₩62.7b market cap, or US$42.4m). Annuncio • Apr 16
Xcure Corp. announced that it expects to receive KRW 10 billion in funding Xcure Corp. announced a private placement of Series 5 Unregistered interest-free private convertible bonds of the company to raise gross proceeds of KRW 10,000,000,000 on April 14, 2026. The transaction includes participation from Skyline Fund . The Bonds are 100% convertible into 4,081,633 common shares of the company at a conversion price value of KRW 2450 and carry interest rate of 5% and maturity interest rate of 5%. The conversion billing period starts from May 13, 2027 to April 13, 2029. The transaction has been approved by the board of directors of the company. The transaction is subject to 1 year hold period. The Bonds have a maturity date of May 13, 2029. The transaction is expected to close on May 13, 2026. Annuncio • Mar 13
Xcure Corp., Annual General Meeting, Mar 26, 2026 Xcure Corp., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 117, gwacheon-daero 12-gil, gyeonggi-do, gwacheon South Korea Annuncio • Jan 07
Xcure Corp. announced that it expects to receive KRW 6.000095 billion in funding Xcure Corp. announced a private placement to issue 5,021,000 shares at an issue price of KRW 1,195 per share for gross proceeds of KRW 6,000,095,000 on January 5, 2026. The transaction will include participation from new investor Ray Fund. The transaction has been approved by shareholders, expected to close on March 03, 2026, restricted to a hold period. New Risk • Nov 15
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2024 fiscal period end). Shareholders have been substantially diluted in the past year (115% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩29.1b market cap, or US$20.0m). New Risk • Oct 28
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Shareholders have been substantially diluted in the past year (115% increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Market cap is less than US$100m (₩33.1b market cap, or US$23.1m). New Risk • Sep 20
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 115% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (115% increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩37.5b market cap, or US$26.9m). Annuncio • Aug 08
Xcure Corp. has completed a Follow-on Equity Offering in the amount of KRW 10.837607 billion. Xcure Corp. has completed a Follow-on Equity Offering in the amount of KRW 10.837607 billion.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 7,945,460
Price\Range: KRW 1364
Discount Per Security: KRW 27.28
Transaction Features: Rights Offering New Risk • Jun 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Shareholders have been substantially diluted in the past year (35% increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Market cap is less than US$100m (₩25.9b market cap, or US$18.8m). Annuncio • Mar 06
Xcure Corp., Annual General Meeting, Mar 20, 2025 Xcure Corp., Annual General Meeting, Mar 20, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 117, gwacheon-daero 12-gil, gyeonggi-do, gwacheon South Korea New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 35% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (35% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (₩34.7b market cap, or US$23.8m). New Risk • Jan 14
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Shareholders have been diluted in the past year (35% increase in shares outstanding). Market cap is less than US$100m (₩37.3b market cap, or US$25.6m). New Risk • Dec 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (₩25.3b market cap, or US$17.6m). New Risk • Dec 07
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2013. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2013 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (₩23.5b market cap, or US$16.5m). New Risk • Sep 30
New minor risk - Financial data availability Less than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (24% average weekly change). Minor Risks Less than 3 years of financial data is available. Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (₩39.7b market cap, or US$30.4m). New Risk • Sep 11
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 13% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (24% average weekly change). Minor Risks Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (₩45.5b market cap, or US$34.0m). Annuncio • Jul 19
Xcure Corp. announced that it expects to receive KRW 15.99999821 billion in funding Xcure Corp. announced a private placement to issue 1,940,805 shares at an issue price of KRW 4,122 per share for the gross proceeds of KRW 7,999,998,210 and 1% Series 3 Anonymous Unsecured Convertible Bonds for the gross proceeds of KRW 8,000,000,000; aggregate gross proceeds of KRW 15,999,998,210 on July 17, 2024. The transaction will include participation from new investor AI Mindbot Equity. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on September 25, 2024.
Series 3 bonds - The transaction will include participation from new investor Jijangjeon Co., Ltd. The bonds are 100% convertible into 1,514,004 common shares at a fixed conversion price of KRW 5,284 from September 25, 2025 to August 25, 2027. The bonds bear 1% coupon rate, 2% maturity rate and matures on September 25, 2027. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on September 25, 2024. Buy Or Sell Opportunity • Jul 17
Now 28% overvalued after recent price rise Over the last 90 days, the stock has risen 105% to ₩6,290. The fair value is estimated to be ₩4,908, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 351% over the last year. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jul 02
Now 29% undervalued Over the last 90 days, the stock has risen 7.6% to ₩3,255. The fair value is estimated to be ₩4,565, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 351% over the last year. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Jun 27
Now 28% undervalued Over the last 90 days, the stock has risen 13% to ₩3,290. The fair value is estimated to be ₩4,573, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 351% over the last year. Meanwhile, the company became loss making. New Risk • Jun 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩26.8b market cap, or US$19.3m). New Risk • Jan 17
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended September 2013. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2013 fiscal period end). Minor Risk Market cap is less than US$100m (₩21.7b market cap, or US$16.1m). New Risk • Dec 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (₩22.0b market cap, or US$16.8m). Valuation Update With 7 Day Price Move • Nov 23
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩3,205, the stock trades at a trailing P/E ratio of 30.3x. Average trailing P/E is 11x in the Tech industry in South Korea. Negligible returns to shareholders over past year. Annuncio • Feb 17
Xcure Corp. announced that it has received KRW 3 billion in funding Xcure Corp. announced a private placement of series 2 Unsecured privately placed convertible bonds with bearer interest for the gross proceeds of KRW 3,000,000,000 on February 15, 2023. The transaction included participation from individual investor Na Hak-rok for KRW 3,000,000. The bonds bear 1% interest rate and 2% yield to maturity and are 100% convertible into 757,193 shares at a fixed conversion price of KRW 3,962 from February 15, 2024 to January 15, 2026 and will mature on February 15, 2026. The transaction has been approved by the board of directors and is expected to close on February 15 2023. The bonds are restricted to a hold period of one year from the date of issuance. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 06
Investor sentiment improved over the past week After last week's 16% share price gain to ₩4,075, the stock trades at a trailing P/E ratio of 26.4x. Average trailing P/E is 12x in the Tech industry in South Korea. Total loss to shareholders of 25% over the past three years. Valuation Update With 7 Day Price Move • Jul 18
Investor sentiment improved over the past week After last week's 17% share price gain to ₩3,050, the stock trades at a trailing P/E ratio of 35.7x. Average trailing P/E is 9x in the Tech industry in South Korea. Total loss to shareholders of 41% over the past three years. Valuation Update With 7 Day Price Move • Jun 17
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩2,675, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 10x in the Tech industry in South Korea. Total loss to shareholders of 42% over the past three years. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.